Activation of the Enzymic Activity of Hepatic Lipase by Apolipoprotein A‐II: Characterization of a Major Component of High Density Lipoprotein as the Activating Plasma Component in vitro
The DOI matches its Crossref record.
Abstract
Human post‐heparin plasma contains two major lipases, lipoprotein lipase and hepatic lipase. Lipoprotein lipase has been investigated extensively and in the presence of a specific activator, apolipoprotein C‐II, is of major importance in modulating the hydrolysis of triacylglycerol rich lipoprotein particles in plasma. The metabolic function and regulation of hepatic lipase is less well established. We have reported previously that apolipoprotein A‐II(apoA‐II)in vitro increased the activity of hepatic lipase by 3.6‐fold [Jahn et al. (1981) FEBS Lett. 131, 366–368]. We have extended these studies and report here the effects of normal plasma, very low density, low density and high density lipoproteins (VLDL, LDL and HDL) and apolipoproteins A‐I, A‐II, C‐I, C‐II and C‐III on hepatic lipase enzymic activity. Normal plasma and HDL activated hepatic lipase by 255 ± 53% (n = 9) and 288 ± 55% (n = 7) respectively, whereas VLDL inhibited hepatic lipase to 25% and LDL did not affect hepatic lipase enzymic activity (n = 7). Isolated apoA‐I, apoC‐I, apoC‐II, and apoC‐III inhibited hepatic lipase enzymic activity to 25 ± 8% (n = 5), 25 ± 15% (n = 5), 23 ± 7% (n = 5) and 13 ± 10% (n = 5) of the basal level. ApoA‐II recombined with HDL lipids activated by 273 ± 42% (n = 5) whereas apoC‐III recombined with HDL lipids inhibited hepatic lipase to 30% of basal activity. Activation of hepatic lipase by apoA‐II was dependent on temperature and pH, with maximal activation (5.75‐fold over basal levels) occurring at pH 7.5 and 37°C. The addition of lipid‐free apoA‐II 10 min after the hydrolysis of triacylglycerol by hepatic lipase had begun resulted in an increase in rate from 1.9 nmol min−1 ml−1 to 7.0 nmol min−1 ml−1. The rate observed by the addition of apoA‐II before the start of the reaction was 9.5 nmol min−1 ml−1. These results are consistent with the concept that apoA‐II modulates the enzymic activity of hepatic lipase, and may play a role in vivo in the regulation of hepatic lipase activity and HDL lipoprotein metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Genetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
Zannis, V. I., Kardassis, D., & Zanni, E. E. (1993) · Advances in Human Genetics 21 · doi:10.1007/978-1-4615-3010-7_3 · Cited by 78
Genetic Mutations Affecting Human Lipoprotein Metabolism
Zannis, V. I., & Breslow, J. L. (1985) · Advances in Human Genetics 14 · doi:10.1007/978-1-4615-9400-0_3 · Cited by 65
Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects
Cohn, J. S., Tremblay, M., Batal, R., Jacques, H., Veilleux, L., Rodriguez, C., Bernier, L., Mamer, O., & Davignon, J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200055-jlr200 · Cited by 41
Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans
Cohn, J. S., Batal, R., Tremblay, M., Jacques, H., Veilleux, L., Rodriguez, C., Mamer, O., & Davignon, J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300209-jlr200 · Cited by 35
“For example, apoC-I has been shown to activate lecithin:cholesterol acyltransferase (LCAT) (11-13), inhibit hepatic lipase (14,15), inhibit phospholipase A2 (16), and also reduce cholesterol ester transfer protein activity (17,18).”
BackgroundBaldo-Enzi, G., Baiocchi, M. R., Grotto, M., Floreani, A. R., Zagolin, M., Chiaramonte, M., Cera, F., & Fellin, R. (1988) · Digestive Diseases and Sciences · doi:10.1007/bf01536666 · Cited by 18
Metadata
- Authors
- JAHN, C. E., OSBORNE, J. C., SCHAEFER, E. J., & BREWER, H. B.
- Venue
- European Journal of Biochemistry
- Publisher
- Wiley
- Published
- 1983-03
- Volume
- 131
- Issue
- 1
- Pages
- 25-29
- ISSN
- 0014-2956 (ISSN-L)
- 1432-1033
- OpenAlex
- W1486193263
- Cited by
- 95
- References
- 0
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activation of the Enzymic Activity of Hepatic Lipase by Apolipoprotein A‐II: Characterization of a Major Component of High Density Lipoprotein as the Activating Plasma Component in vitro. https://app.cochat.ai/papers/10.1111/j.1432-1033.1983.tb07227.x
- The paper
- JAHN, C. E., OSBORNE, J. C., SCHAEFER, E. J., & BREWER, H. B. (1983). Activation of the Enzymic Activity of Hepatic Lipase by Apolipoprotein A‐II: Characterization of a Major Component of High Density Lipoprotein as the Activating Plasma Component in vitro. European Journal of Biochemistry. https://doi.org/10.1111/j.1432-1033.1983.tb07227.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.